| Future prospects for noncanonical amino acids in biological therapeutics A Rezhdo, M Islam, M Huang, JA Van Deventer Current opinion in biotechnology 60, 168-178, 2019 | 69 | 2019 |
| Chemical diversification of simple synthetic antibodies M Islam, HP Kehoe, JB Lissoos, M Huang, CE Ghadban, ... ACS chemical biology 16 (2), 344-359, 2021 | 22 | 2021 |
| Chemical screens identify drugs that enhance or mitigate cellular responses to antibody-toxin fusion proteins A Antignani, L Mathews Griner, R Guha, N Simon, M Pasetto, J Keller, ... PLoS One 11 (8), e0161415, 2016 | 11 | 2016 |
| More fruitful and robust hole expansion testing conditions J Goncalves, D Fouques, X Bellut, L Zhang, M Huang, JV Deventer, ... Proc. IDDRG 2014 (Paris), 216-221, 2014 | 8 | 2014 |
| Systematic evaluation of protein-small molecule hybrids on the yeast surface M Huang, M Rueda-Garcia, A Harthorn, BJ Hackel, JA Van Deventer ACS Chemical Biology 19 (2), 325-335, 2024 | | 2024 |
| Abstract A67: The mTOR inhibitor, everolimus, enhances the cytotoxicity of pseudomonas-based immunotoxins: Mechanistic insights A Antignani, L Mathews-Griner, M Ferrer, N Simon, E Angelus, M Huang, ... Molecular Cancer Research 14 (1_Supplement), A67-A67, 2016 | | 2016 |
